Timing of dental development in osteogenesis imperfecta patients with and without bisphosphonate treatment

• Published in: Bone (New York, N.Y.) N.Y.), 2017-01, Vol.94, p.29-33
• Main Authors: Vuorimies, Ilkka, Arponen, Heidi, Valta, Helena, Tiesalo, Outi, Ekholm, Marja, Ranta, Helena, Evälahti, Marjut, Mäkitie, Outi, Waltimo-Sirén, Janna
• Format: Article
• Language: English
• Subjects: Adolescent; Bisphosphonate; Bone Resorption - complications; Bone Resorption - diagnostic imaging; Bone Resorption - drug therapy; Child; Child, Preschool; Diphosphonates - pharmacology; Diphosphonates - therapeutic use; Female; Fracture; Humans; Male; Medicin och hälsovetenskap; Odontogenesis - drug effects; Orthopedics; Osteoclast; Osteogenesis Imperfecta - diagnostic imaging; Osteogenesis Imperfecta - drug therapy; Osteogenesis Imperfecta - pathology; Pediatrics; Pharmacology; Time Factors; Tooth, Deciduous - diagnostic imaging; Tooth, Deciduous - drug effects; Tooth, Deciduous - pathology
• ISSN: 8756-3282; 1873-2763; 1873-2763
• DOI: 10.1016/j.bone.2016.10.004

Abstract Bisphosphonates have established their role as medical therapy for pediatric osteogenesis imperfecta (OI) patients. Since bisphosphonates have also been shown to delay tooth development in animal models, we aimed to assess whether the medication has a similar effect on children with OI. In this cross-sectional study, bisphosphonate-treated OI patients of whom dental panoramic tomograph was taken between 3 and 16 years of age formed the study group. The patients, 22 in total, had been treated with pamidronate, zoledronic acid or risedronate for at least one year before the radiography. Developmental stage of the permanent teeth, resorption of the deciduous teeth, and number of the erupted permanent teeth were radiographically assessed in the left mandibular quadrant. Dental panoramic tomographs of 50 OI patients, naïve to bisphosphonates, and of 50 healthy individuals of the same age were used as controls. The dental development was statistically significantly accelerated in the OI group naïve to bisphosphonates showing median advancement of dental age by 0.63 years from chronological age and median increase in the number of erupted teeth by 0.31 as compared to Finnish norms. Bisphosphonate-treated OI patients displayed, however, age-appropriate dental development. The OI patients not treated with bisphosphonates also showed statistically significantly faster resorption of the deciduous teeth than the treated ones, and displayed an altered interrelationship between the resorption stage of an individual primary tooth and the developmental stage of the succedaneous permanent tooth, unlike the OI patients treated with bisphosphonate. No correlation between either cumulative bisphosphonate dose or between treatment length and any measured component of the dental development was found. To conclude, OI itself was found to lead to advanced dental development. Bisphosphonate treatment had a delaying effect in all the three aspects studied, resulting in a rate of dental development indistinguishable from normal.